Gibson Dunn

From the Derivatives Practice Group: This week, the CFTC issued a staff advisory concerning its new policy on cooperation in … The post Derivatives, Legislative and Regulatory Weekly Update (May 22, 2026) appeared first on Gibson Dunn .

Partner Hillary Holmes was quoted by International Financing Review in its article “Small U.S. IPOs Remain in the Shadows.” The post Hillary Holmes Quoted by International Financing Review About Smaller Business IPOs appeared first on Gibson Dunn .

The SEC is seeking comments on a variety of aspects of the proposed amendments, including on whether any additional accommodations … The post SEC Proposes Amendments to Streamline and Recalibrate Filer Status Determinations and Related Reporting Obligations appeared first on Gibson Dunn .

The proposals reflect the most coordinated effort in two decades to address concerns about the shrinking public-company population, the high … The post SEC Proposes Broad Amendments to Registered Offering Framework appeared first on Gibson Dunn .

The Los Angeles Times has recognized Gibson Dunn as the largest law firm in Los Angeles County, with 309 lawyers. The post Los Angeles Times Names Gibson Dunn Largest Law Firm in Los Angeles County appeared first on Gibson Dunn .

Gibson Dunn is representing Concentra Biosciences, an affiliate of Tang Capital Management, on its acquisition of CARGO Therapeutics, Inc. (Nasdaq: … The post Gibson Dunn Advises Concentra Biosciences on Acquisition of CARGO Therapeutics, Inc. appeared first on Gibson Dunn .

Gibson Dunn represented XOMA Royalty Corporation in connection with the acquisition of ESSA Pharma Inc. (Nasdaq: EPIX) by XenoTherapeutics, Inc., … The post Gibson Dunn Advises XOMA Royalty Corporation in Connection with Acquisition of ESSA Pharma by XenoTherapeutics appeared first on Gibson Dunn .

Gibson Dunn is representing Concentra Biosciences, an affiliate of Tang Capital Management, on its acquisition of iTeos Therapeutics, Inc. (Nasdaq: … The post Gibson Dunn Advises Concentra Biosciences on Acquisition of iTeos Therapeutics, Inc. appeared first on Gibson Dunn .

Gibson Dunn is advising US WorldMeds, a specialty pharmaceutical company, on its acquisition of Adaptimmune Therapeutics’s TECELRA, lete-cel, afami-cel, and … The post Gibson Dunn Advises US WorldMeds on Acquisition of Adaptimmune Therapeutics’s TECELRA, lete-cel, afami-cel, and uza-cel Cell Therapies and Concurrent Financing appeared first on Gibson Dunn .

Gibson Dunn is representing Shattuck Labs, Inc. in connection with a private placement of securities expected to generate aggregate gross … The post Gibson Dunn Advises Shattuck Labs on Private Placement of Up to Approximately $103 Million appeared first on Gibson Dunn .

Gibson Dunn represented Arrowhead Pharmaceuticals on the signing of an asset purchase agreement between Sanofi and Visirna Therapeutics, a majority-owned … The post Gibson Dunn Advises Arrowhead Pharmaceuticals on Signing of Asset Purchase Agreement Between Sanofi and Visirna Therapeutics appeared first on Gibson Dunn .

Gibson Dunn represented Neurogene Inc. on establishing an at-the-market facility for the sale of up to $150 million of its … The post Gibson Dunn Advises Neurogene Inc. on Establishing At-the-Market Facility for Sale of up to $150 Million of Common Stock appeared first on Gibson Dunn .

Gibson Dunn is representing XOMA Royalty Corporation, a publicly traded biotech royalty aggregator, on its acquisition of HilleVax, Inc. (Nasdaq: … The post Gibson Dunn Advises XOMA Royalty Corporation on Acquisition of HilleVax, Inc. appeared first on Gibson Dunn .

Partner and Appellate and Constitutional Law Practice Group Co-Chair Jeff Wall joined the Law.com “Supreme Court Brief” podcast to discuss topics including his career and the debate over the U.S. Supreme Court’s emergency docket. The post Jeff Wall Discusses Career and Supreme Court With Law.com’s “Supreme Court Brief” Podcast appeared first on Gibson Dunn .

Defense teams led by Bill Burck and Avi Perry of Quinn Emanuel Urquhart & Sullivan and Reed Brodsky of Gibson, Dunn & Crutcher won jury acquittals for the two co-CEOs of Next Jump in a public corruption case where federal prosecutors previously won the conviction of the Navy official they were accused of bribing for military contracts. The post Litigator of the Week Runners-Up and Shout-Outs appe…

The SEC’s rescission of its longstanding “no-deny” policy could have profound implications for how parties approach settlement strategy and manage … The post Undeniably Deniable: SEC Rescinds Policy on Denials of Enforcement Settlements appeared first on Gibson Dunn .

The Gibson Dunn Data Centers and Digital Infrastructure Practice Group is closely monitoring legislative, regulatory, and political developments regarding the growth of data centers. The post DOE’s Emergency Order Signals New Role for Data Centers’ Backup Power appeared first on Gibson Dunn .

Gibson Dunn is advising Mentari Therapeutics, Inc. on its merger with InMed Pharmaceuticals, Inc. and concurrent $290 million private placement. The post Gibson Dunn Advises Mentari Therapeutics on Merger With InMed Pharmaceuticals and Concurrent $290 Million Private Placement appeared first on Gibson Dunn .

MV Transportation, Inc. v. GDS Transport, LLC, No. 24-0924 – Decided May 8, 2026; In re Home Depot U.S.A., Inc., No. … The post Texas Supreme Court Reinforces Rule 91a as a Tool for Early Resolution of Dispositive Legal Issues appeared first on Gibson Dunn .

Gibson Dunn’s ERISA litigation update summarizes key legal opinions and developments during the past quarter to assist plan sponsors and … The post First Quarter 2026 ERISA Litigation Update appeared first on Gibson Dunn .